Ximena A. Levander, M.D., MCR

Dr. Levander is an Assistant Professor of Medicine and Clinician Investigator at OHSU in the Division of General Internal Medicine and Geriatrics, Addiction Medicine Section. Her research interests focus on developing and implementing effective and innovative interventions for delivering evidence-based substance use disorder treatment in a patient-centered approach to people who use drugs. She is currently funded by a Learning Health Systems Science K12 to evaluate utilization of telemedicine for treatment of opioid use disorder and is a member of the OHSU Digital Health prototyping team. She is interested in how to ensure equitable access to addiction treatment using telemedicine and how telemedicine could expand access particularly to those with barriers to care including those living in rural communities, those experiencing homelessness, and women. In her current clinical practice, she splits her time working at the OHSU outpatient addiction and complex pain (ACP) clinic, on the OHSU inpatient addiction consult service (IMPACT), and at a harm reduction low-barrier buprenorphine bridge clinic (HRBR). She received a B.S. from Vanderbilt University and M.D. from Weill Cornell Medical College. She completed residency in internal medicine/primary care at University of Washington and fellowships in addiction medicine and Samuel Wise General Internal Medicine Clinical Research at OHSU.